Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 3,500 Shares of Teleflex Incorporated (NYSE:TFX)

Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in Teleflex Incorporated (NYSE:TFX) by 43.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,644 shares of the medical technology company’s stock after purchasing an additional 3,500 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Teleflex were worth $2,072,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in TFX. Avior Wealth Management LLC raised its holdings in Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 101 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in Teleflex in the third quarter worth about $40,000. True Wealth Design LLC raised its holdings in Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 166 shares in the last quarter. Capital Performance Advisors LLP bought a new position in Teleflex in the third quarter worth about $54,000. Finally, Banque Cantonale Vaudoise grew its stake in shares of Teleflex by 184.8% during the third quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock worth $56,000 after acquiring an additional 146 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on TFX. Mizuho dropped their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Royal Bank of Canada dropped their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Truist Financial dropped their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Teleflex currently has a consensus rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Price Performance

Shares of NYSE TFX opened at $177.45 on Thursday. The business’s 50 day moving average price is $177.07 and its 200 day moving average price is $206.17. The firm has a market cap of $8.24 billion, a P/E ratio of 35.28, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex Incorporated has a 52 week low of $165.62 and a 52 week high of $249.90. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.